Cargando…
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease
Fabry disease is an X-linked lysosomal disease in which defects in the alpha-galactosidase A enzyme activity lead to the ubiquitous accumulation of glycosphingolipids. Whereas the classic disease is characterized by neuropathic pain, progressive renal failure, white matter lesions, cerebral stroke,...
Autores principales: | Mauhin, Wladimir, Tebani, Abdellah, Amelin, Damien, Abily-Donval, Lenaig, Lamari, Foudil, London, Jonathan, Douillard, Claire, Dussol, Bertrand, Leguy-Seguin, Vanessa, Noel, Esther, Masseau, Agathe, Lacombe, Didier, Maillard, Hélène, Bekri, Soumeya, Lidove, Olivier, Benveniste, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911241/ https://www.ncbi.nlm.nih.gov/pubmed/35268324 http://dx.doi.org/10.3390/jcm11051233 |
Ejemplares similares
-
A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease
por: Tebani, Abdellah, et al.
Publicado: (2020) -
Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2020) -
Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era
por: Tebani, Abdellah, et al.
Publicado: (2016) -
Parsing Fabry Disease Metabolic Plasticity Using Metabolomics
por: Ducatez, Franklin, et al.
Publicado: (2021) -
Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY
por: Mauhin, Wladimir, et al.
Publicado: (2018)